A Randomized, Double-blind, Multi-center, Phase 3 Trial to Evaluate the Efficacy and Safety of a CKD-330 Versus Amlodipine Monotherapy in Hypertensive Patients Inadequately Controlled by Amlodipine Monotherapy

Trial Profile

A Randomized, Double-blind, Multi-center, Phase 3 Trial to Evaluate the Efficacy and Safety of a CKD-330 Versus Amlodipine Monotherapy in Hypertensive Patients Inadequately Controlled by Amlodipine Monotherapy

Completed
Phase of Trial: Phase III

Latest Information Update: 10 Oct 2016

At a glance

  • Drugs Amlodipine/candesartan-cilexetil (Primary) ; Amlodipine
  • Indications Hypertension
  • Focus Therapeutic Use
  • Sponsors Chong Kun Dang
  • Most Recent Events

    • 04 Oct 2016 Status changed from active, no longer recruiting to completed.
    • 15 Jul 2016 Planned End Date changed from 1 Dec 2016 to 1 Oct 2016.
    • 15 Jul 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Aug 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top